{"title":"Table of Contents","authors":"","doi":"10.1002/gpu.20131","DOIUrl":null,"url":null,"abstract":"<p>Cholinesterase Inhibitors in Alzheimer's Disease: Optimal Treatment Strategies</p><p>Antidepressant Side Effects, Interactions and Their Impact on Adherence</p><p>Risk of Venous Thromboembolism With Antipsychotics</p><p>Adjunctive Rivastigmine Not Beneficial for Delirium in Critically Ill Patients</p><p>Switching Cholinesterase Inhibitors Reasonable Option for AD Patients</p><p>Discontinuing Cholinesterase Inhibitors</p><p>Visual Hallucinations Resolved With Donepezil</p><p>Rivastigmine and REM Sleep Behavior Disorder</p><p>New Approvals</p><p>Warnings on OTC Chelation Products</p>","PeriodicalId":101224,"journal":{"name":"The Brown University Geriatric Psychopharmacology Update","volume":"15 1","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2010-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/gpu.20131","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Geriatric Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/gpu.20131","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Cholinesterase Inhibitors in Alzheimer's Disease: Optimal Treatment Strategies
Antidepressant Side Effects, Interactions and Their Impact on Adherence
Risk of Venous Thromboembolism With Antipsychotics
Adjunctive Rivastigmine Not Beneficial for Delirium in Critically Ill Patients
Switching Cholinesterase Inhibitors Reasonable Option for AD Patients
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
